[11C]hyaluronan uptake with positron emission tomography in liver disease

European Journal of Clinical Investigation

Volumn 30, Issue 7, 2000, Pages 600-607

  Lindqvist, U ^a   Westerberg, G ^a   Bergstrom M ^a   Torsteindottir, I ^a   Gustafson, S ^b   Sundin, A ^a   Loof L ^a   Langstrom B ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

Healthy; Hyaluronan; Liver disease; Metabolic process

Indexed keywords

CARBON 11; HYALURONIC ACID; RADIOPHARMACEUTICAL AGENT; CARBON; DIAGNOSTIC AGENT;

ADULT; AGED; ALCOHOL LIVER CIRRHOSIS; ALCOHOL LIVER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG ELIMINATION; DRUG UPTAKE; FATTY LIVER; HEPATITIS; HUMAN; LOADING TEST; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; CLINICAL TRIAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; FEMALE; LIVER DISEASE; METABOLISM; METHODOLOGY; MIDDLE AGED; SCINTISCANNING;

ADULT; AGED; CARBON RADIOISOTOPES; FEMALE; HUMANS; HYALURONIC ACID; LIVER DISEASES; MALE; MIDDLE AGED; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0033623745     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2000.00675.x     Document Type: Article

References (26)

1. 1 Heinegard D, Paulsson M. Structure and metabolism of proteoglycans. In: Piez K, Reddi AH, editors. Extracellular Matrix Biochemistry, 1st ed. New York: Elsevier; 1984. p.277-322.
2. 2 Laurent TC, Fraser JRE. Hyaluronan. FASEB J 1992;6:2397-404.
3. 3 Laurent UBG, Laurent TC. On the origin of hyaluronan in blood. Biochem Intern 1981;2:195-9.
4. 4 Tengblad A, Laurent UBG, Lilja K, Cahill RNP, Engström-Laurent A, Fraser JRE et al. Concentration and molecular mass of hyaluronate in lymph and blood. Biochem J 1986;236:521-5.
5. 5 Fraser JRE, Laurent TC, Pertoft H, Baxter E. Plasma clearance, tissue distribution and metabolism of hyaluronic acid injected intravenously in the rabbit. Biochem J 1981;200:415-24.
6. 6 Smedsrød B, Pertoft H, Eriksson S, Fraser JRE, Laurent TC. Studies in vitro on the uptake and degradation of sodium hyaluronate in rat liver endothelial cells. Biochem J 1984;223:617-26.
7. 7 Fraser JRE, Alcorn D, Laurent TC, Robinson AD, Ryan GB. Uptake of circulating hyaluronic acid by rat liver. Cellular localization in situ. Cell Tissue Res 1985;242:505-10.
8. 8 Henriksen JH, Bentsen KD, Laurent TC. Splanchnic and renal extraction of circulating hyaluronan in patients with alcoholic liver disease. J Hepatol 1988;6:158-66.
9. 9 Engström-Laurent A, Laurent UBG, Lilja K, Laurent TC. Concentration of sodium hyaluronate in serum. Scand J Clin Lab Invest 1985;45:497-504.
10. 10 Lindqvist U, Laurent TC. Serum hyaluronan and aminoterminal propeptide of type III procollagen: variation with age. Scand J Clin Lab Invest 1992;52:613-21.
11. 11 Engström-Laurent A, Lööf L, Nyberg A, Schröder T. Increased serum levels of hyaluronate in liver disease. Hepatology 1985;4:638-42.
12. 12 Frébourg T, Delpech B, Bercoff E, Senate J, Bertrand P, Deugnier Y et al. Serum hyaluronate in liver diseases: study by enzymoimmunological assay. Hepatology 1986;6:392-5.
13. 13 Gibson PR, Fraser JRE, Brown TJ, Finch CF, Jones PA, Coleman JC et al. Hemodynamic and liver function predictors of serum hyaluronan in alcoholic liver disease. Hepatology 1992;6:1054-9.
14. 14 Nyberg A, Engström-Laurent A, Lööf L. Serum hyaluronate in primary biliary cirrhosis - A biochemical marker for progressive liver damage. Hepatology 1988;8:142-6.
15. 15 Nyberg A, Lindqvist U, Engström-Laurent A. Serum hyaluronan and aminoterminal propeptide of type III collagen in primary biliary cirrhosis: relation to clinical symptoms, liver histopathology and outcome. J Int Med 1992;231:485-91.
16. 16 Adams DH, Wang L, Hubscher SC, Neuberger JM. Hepatic endothelial cells. Target in allograft rejection? Transplantation 1989;47:479-82.
17. 17 Lebel L, Gabrielsson J, Laurent TC, Gerdin B. Kinetics of circulating hyaluronan in humans. Eur J Clin Invest 1994;24:621-6.
18. 18 Lindqvist U, Groth T, Lebel L. Evaluation of various models of hyaluronan kinetics for assessment of liver function. Scand J Clin Lab Invest 1997;57:49-58.
19. 19 Lindqvist U, Groth T, Lööf L, Hellsing K. A hyaluronan-loading test applied to patients with liver and joint diseases. Clin Chem Acta 1992;210:119-32.
20. 11C-hyaluronan. Nucl Med Biol 1995;22:251-6.
21. 21 Lebel L, Smith L, Risberg B, Laurent TC, Gerdin B. Increased lymphatic elimination of interstitial hyaluronan during E.coli sepsis in sheep. Am J Physiol 1989;256:(Heart Circ Physiol 1989:25):H1524-31.
22. 125Ityrosine: studies in vitro and in vivo in the rat. Glycoconjugate J 1994;11:608-13.
23. 23 Brandt R, Hedlöf E, Åsman I, Bucht A, Tengblad A. A convenient radiometric assay for hyaluronan. Acta Otolaryngol (Stockholm) Supplement 1987;442:31-5.
24. 24 Kops ER, Herzog H, Schmid A, Holte S, Feinendegen LE. Performance characteristics of an eight-ring whole body PET scanner. J Comput Assist Tomogr 1990;14 (3):437-45.
25. 25 Patlak CS, Blasberg RG, Fenstermacher JD. Graphic evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metabol 1983;3:1-7.
26. 26 Albers I, Hartmann H, Bircher J, Creutzfeldt W. Superiority of the Child-Pugh classification to quantitative liver function tests for assessing prognosis of liver cirrhosis. Scand J Gastroenterol 1989;24:269-76.